Latest News
Tenaya Therapeutics reports interim RIDGE-1 data showing reduced arrhythmia burden with TN-401
...
SN BioScience reports first patient dosed in global Phase 1b/2 clinical trial of SNB-101
15 May 2026 - SN BioScience Inc, a clinical-stage biotechnology company based in South Korea, announced on Thursday that it has started the first patient dosing in its global Phase 1b/2 clinical trial evaluating SNB-101 (API: SN-38), a nanoparticle a...
Apotex announces commercial launch of Apo-Semaglutide Injection in Canada
15 May 2026 - Apotex Inc, a Canada-based global health company, announced on Thursday the commercial launch in Canada of Apo-Semaglutide Injection, a generic equivalent of Ozempic.The product will be available across Canada within the coming weeks.Ap...
US FDA approves Datar Cancer Genetics' comprehensive genomic profiling assay for solid tumours
15 May 2026 - Precision oncology company Datar Cancer Genetics (DCG) announced on Thursday that the US Food and Drug Administration (FDA) has cleared its tissue-based comprehensive genomic profiling (CGP) assay for all solid tumours.CellDx-Tissue, a ...
Intensity Therapeutics receives Cancer Treatment Technology Innovator of the Year award
15 May 2026 - Intensity Therapeutics Inc (Nasdaq:INTS), a late-stage clinical biotechnology company, announced on Thursday that it has been named a winner of the 2026 GHP Magazine Healthcare & Pharmaceutical Awards as the Cancer Treatment Technol...